These patients had a very long interval between the PBC and BM (185 and 250 months, respectively), along which they received several years of hormonal-therapy that had led to the acquisition of the ESR1 mutation conferring therapeutic resistance [18]. Here, ESR1 is linked to primary biliary cholangitis.